{
    "clinical_study": {
        "@rank": "16461", 
        "acronym": "VALID0", 
        "arm_group": [
            {
                "arm_group_label": "Raspberry", 
                "arm_group_type": "Experimental", 
                "description": "Raspberry taste valacyclovir solution"
            }, 
            {
                "arm_group_label": "Orange", 
                "arm_group_type": "Experimental", 
                "description": "Orange taste valacyclovir solution"
            }, 
            {
                "arm_group_label": "Plain", 
                "arm_group_type": "Active Comparator", 
                "description": "Plain valacyclovir solution"
            }
        ], 
        "brief_summary": {
            "textblock": "Palatability testing of 3 different formulations of a newly developed paediatric\n      valacyclovir oral solution in children 4-12 years of age and at least one of their parents.\n      Children will be included, who received (val)acyclovir prophylaxis in the past, or will\n      probably need it in the future i.e. children with primary immune deficiency or cancer."
        }, 
        "brief_title": "Palatability Testing of a New Paediatric Formulation of Valacyclovir - VALID 0", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Varicella Zoster Virus Infection", 
            "Herpes Simplex Virus Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Chickenpox", 
                "Herpes Zoster", 
                "Herpes Simplex", 
                "Virus Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is at least 4 years of age.\n\n          -  Subject weighs at least 15kg.\n\n          -  Subject is capable of performing the taste assessment, according to the\n             investigator's judgement.\n\n          -  The child and parent(s) are willing to participate in the taste assessment.\n\n          -  Signed informed consent by the legal guardian for participation of the child and if\n             the parent also wants to participate: signed informed consent for their own\n             participation, prior to start of the study.\n\n        Exclusion Criteria:\n\n          -  Documented history of sensitivity/idiosyncrasy to medicinal products or excipients.\n\n          -  Presence of any condition that influences taste sensation (such as upper respiratory\n             infection, febrile illness within 3 days before the first dose, mucositis or use of\n             medication that influences taste perception, as described in the label information)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682109", 
            "org_study_id": "UMCN-AKF 11.05"
        }, 
        "intervention": {
            "arm_group_label": [
                "Raspberry", 
                "Orange", 
                "Plain"
            ], 
            "description": "Children of 4-8 years will taste 2 ml of each solution and children of 8-12 years and the parent(s) will taste 4 ml of each solution.", 
            "intervention_name": "Valacyclovir", 
            "intervention_type": "Drug", 
            "other_name": "50 mg/ml valacyclovir solution"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Valacyclovir", 
                "Acyclovir"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prophylaxis", 
            "herpes zoster", 
            "herpes simplex", 
            "valacyclovir", 
            "palatability", 
            "paediatric"
        ], 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Nijmegen", 
                    "country": "Netherlands"
                }, 
                "name": "Radboud University Nijmegen Medical Centre"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "3", 
        "official_title": "Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children - VALID 0", 
        "overall_official": {
            "affiliation": "Radboud University", 
            "last_name": "Adilia Warris, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "Netherlands: Ministry of Health, Welfare and Sport", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients (children) will assess the taste of 3 different oral solutions. A questionnaire has to be completed to order the palatability of the three formulations.", 
            "measure": "Selection of oral solution with best taste", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682109"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Children will score the taste of 3 different oral valacyclovir solutions. A 100 mm facial hedonic scale will be employed to indicate the palatability of each formulation.", 
                "measure": "Taste assessment", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "To determine whether parents can predict the palatability preference of their child.", 
                "measure": "Predictability of palatability preference of the child by parents.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "Radboud University", 
        "sponsors": {
            "collaborator": {
                "agency": "ZonMw: The Netherlands Organisation for Health Research and Development", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Radboud University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "August 2013", 
        "why_stopped": "oral liquid not available"
    }
}